相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Phenotypic plasticity during metastatic colonization
Charly Jehanno et al.
TRENDS IN CELL BIOLOGY (2022)
Lipid-coated albumin-paclitaxel nanoparticles loaded with sorcin-siRNA reverse cancer chemoresistance via restoring intracellular calcium ion homeostasis
Chenglong Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Calcium-chelated nanosystem reversing cancer chemoresistance via replenishing intracellular calcium ions
Chenglong Wang et al.
CHEMICAL ENGINEERING JOURNAL (2022)
Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGFβ1-induced epithelial-mesenchymal transition and metastasis of ecolorectal carcinoma
Jing Quan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
CROT (Carnitine O-Octanoyltransferase) Is a Novel Contributing Factor in Vascular Calcification via Promoting Fatty Acid Metabolism and Mitochondrial Dysfunction
Takehito Okui et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment
Katherine C. Kurnit et al.
OBSTETRICS AND GYNECOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
TGFβ signaling networks in ovarian cancer progression and plasticity
Asha Kumari et al.
CLINICAL & EXPERIMENTAL METASTASIS (2021)
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
Wei Cao et al.
CHINESE MEDICAL JOURNAL (2021)
A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer
Jinguo Zhang et al.
ONCOGENE (2021)
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments
Claudia Marchetti et al.
SEMINARS IN CANCER BIOLOGY (2021)
Tumour fatty acid metabolism in the context of therapy resistance and obesity
Andrew J. Hoy et al.
NATURE REVIEWS CANCER (2021)
Reprogramming of fatty acid metabolism in cancer
Nikos Koundouros et al.
BRITISH JOURNAL OF CANCER (2020)
TGF-β1-induced epithelial-mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p-AMPK pathway in breast cancer cells
Qian-Qian Liu et al.
ONCOLOGY REPORTS (2020)
Treatment of epithelial ovarian cancer
Lindsay Kuroki et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Single Cell Gene Co-Expression Network Reveals FECH/CROT Signature as a Prognostic Marker
Xin Chen et al.
CELLS (2019)
miR-126a-5p-Dbp and miR-31a-Crot/Mrpl4 interaction pairs crucial for the development of hypertension and stroke
Qini Zhao et al.
MOLECULAR MEDICINE REPORTS (2019)
Expression of miR-33 from an SREBP2 intron inhibits the expression of the fatty acid oxidation-regulatory genes CROT and HADHB in chicken liver
F. Shao et al.
BRITISH POULTRY SCIENCE (2019)
Bax, Bak and beyond - mitochondrial performance in apoptosis
Aida Pena-Blanco et al.
FEBS JOURNAL (2018)
BCL-2 proteins and apoptosis: Recent insights and unknowns
Frank Edlich
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Age-related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer
Kenji Yoshikawa et al.
MOLECULAR AND CLINICAL ONCOLOGY (2018)
TGF-β Family Signaling in Tumor Suppression and Cancer Progression
Joan Seoane et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Pyridoxine 5′-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer
Lingyun Zhang et al.
CELL DEATH & DISEASE (2017)
Cytidine monophosphate kinase is inhibited by the TGF-β signalling pathway through the upregulation of miR-130b-3p in human epithelial ovarian cancer
Daibing Zhou et al.
CELLULAR SIGNALLING (2017)
TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling
Junqin Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Global trends and predictions in ovarian cancer mortality
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2016)
Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer
Lingyun Zhang et al.
CURRENT CANCER DRUG TARGETS (2016)
Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A review
Eric R. Craig et al.
GYNECOLOGIC ONCOLOGY (2016)
Hepatic miR-33a/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects
Joel Vega-Badillo et al.
LIVER INTERNATIONAL (2016)
Cancer as a metabolic disease: implications for novel therapeutics
Thomas N. Seyfried et al.
CARCINOGENESIS (2014)
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data
Jun-Hao Li et al.
NUCLEIC ACIDS RESEARCH (2014)
Targeting TGF-β signaling in cancer
Lior H. Katz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Changes in carnitine octanoyltransferase activity induce alteration in fatty acid metabolism
Francoise Le Borgne et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Katey J. Rayner et al.
NATURE (2011)
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
Alberto Davalos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy
Jian-Liang Chou et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Regional activation of chromosomal arm 7q with and without gene amplification in taxane-selected human ovarian cancer cell lines
YC Wang et al.
GENES CHROMOSOMES & CANCER (2006)
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy
K Takara et al.
CURRENT PHARMACEUTICAL DESIGN (2006)